Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.

Source:http://linkedlifedata.com/resource/pubmed/id/18047546

Download in:

View as

General Info

PMID
18047546